Denali therapeutics reports fourth quarter and full year 2024 financial results and business highlights

South san francisco, calif., feb. 27, 2025 (globe newswire) -- denali therapeutics inc. (nasdaq: dnli) today reported financial results for the fourth quarter and year ended december 31, 2024, and provided business highlights.

DNLI Ratings Summary

DNLI Quant Ranking